Mehta Integrat. (511377)
Asset PlayScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹36.31 |
| Market Cap | ₹19.11 Cr |
| P/E Ratio | 54.81 |
| ROCE | 2.47% |
| ROE | 1.57% |
| Dividend Yield | 0% |
| Profit Growth | -240% |
| Debt/Equity | — |
| Sales Growth | 0% |
| 52-Week Range | ₹24.06 — ₹36.82 |
| Sector | Finance |
| Book Value | ₹33.14 |
Strengths
- Book value of ₹33.14 per share is close to the current price of ₹36.31, providing tangible asset backing.
- P/B ratio of 1.10 is not demanding if the stated book value proves reliable.
- P/E of 54.81 indicates some small positive annual earnings, despite a weak latest quarter.
- Market cap of ₹19 Cr is tiny, leaving scope for niche opportunities or asset unlocking if management acts wisely.
Concerns
- ROE of 1.57% and ROCE of 2.47% indicate severe value destruction, well below any acceptable cost of capital.
- Profit growth of -240% and latest quarter net profit of approximately ₹0 Cr show deteriorating earnings momentum.
- Sales growth of 0.00% and latest quarter sales of ₹0 Cr raise serious doubts about visible revenue-generating activity.
- Piotroski F-score of 3/9 reflects weak operational and financial health.
AI Analysis
At first glance, Mehta Integrat looks like a business I would walk past. A non-banking finance company commanding a market capitalization of just ₹19 crore, with a P/E of 54.81, is earning hardly anything. ROE of 1.57% and ROCE of 2.47% are far below what an investor can earn in a simple index fund. Graham would ask: is there an asset cushion? Book value is ₹33.14 per share against a price of ₹36.31, so I am paying barely 1.1 times stated book. But book value in a lending or financial company is only useful if the assets are good and earnings support the capital. Here profit growth has collapsed by 240%, the latest quarter shows sales and net profit both effectively zero, and the Piotroski F-score of 3/9 flags real operating and balance-sheet stress. There is no dividend to compensate while waiting. This is not a wonderful business at a fair price; it may be a fair balance sheet at a somewhat fair price. With promoter holding unavailable and data insufficient, I cannot judge governance or inside ownership. The 52-week range shows the price near the upper end, so there is no distressed margin of safety either. As an asset play, the stock is option-like: if book value is genuinely ₹33 and deteriorates no further, downside appears cushioned. But with zero visible revenue and negative profit momentum, value can evaporate quickly. I would need audited details, loan book quality, and capital adequacy before deploying even a small amount. Better to watch from the sidelines.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer